| Date | Title | Description |
| 20.11.2025 | Tariff truce, openness pledges: Firms in China welcome recent positive signals but want to see more | Listen
14 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SHANGHAI: To doTERRA’s China president Owen Messick, the Trump-Xi summit in late October was nothing short of “a very big breakthrough” - a signal of ... |
| 11.11.2025 | Guo Guangchang: Fosun Strengthens Globalization Capabilities, Accelerates Innovation through Open Cooperation | HONG KONG, Nov. 11, 2025 /PRNewswire/ -- On 8 November, Guo Guangchang, Chairman of Fosun International, attended the 3rd Pujiang Biopharmaceutical Original Innovation Conference 2025. During the conference, Guo Guangchang stated, "At ... |
| 27.03.2025 | Henlius and Fosun Pharma: Navigating the Future of Healthcare Innovation | In the bustling landscape of global healthcare, two Chinese pharmaceutical giants, Henlius and Fosun Pharma, are carving their paths with innovation and strategic growth. Their recent annual results paint a vivid picture of resilience and a... |
| 26.03.2025 | Fosun Pharma Announces 2024 Annual Results | Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY
SHANGHAI, March 26, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the G... |
| 28.01.2025 | Peytant Solutions hires chief medical and commercial officers | Peytant Solutions today announced it hired Dr. Craig Walker as chief medical officer after naming JD Simpson as chief commercial officer last week.
The Plymouth, Minnesota-based stent maker won FDA de novo marketing authorization for its AM... |
| 27.01.2025 | Asia's Venture Capital Landscape: A Tale of Peaks and Valleys | The venture capital scene in Asia is a rollercoaster ride. Last year, it hit a low that echoed the past. The funding market plummeted to $65.8 billion, matching the dismal figures of 2014. It’s a stark reminder that what goes up can come cr... |
| 27.01.2025 | China Leads Asia’s Venture Downturn — But Other Countries Didn’t Help | 0 Shares Email Facebook Twitter LinkedIn
Last year the Asia funding market tanked, reaching only $65.8 billion — the exact same low the market hit in 2014.
While the fourth quarter showed a little resilience — bouncing back after a slow Q3 ... |
| 22.01.2025 | Peytant Solutions Welcomes JD Simpson as Chief Commercial Officer | JD Simpson, Chief Commercial Officer, Peytant Solutions
Peytant Solutions Inc., a medical technology company pioneering the use of amnion-based covered scaffolds for the treatment of luminal disease, announced the appointment of JD Simpson ... |
| 08.11.2024 | Fosun's Bold Steps at CIIE: A Gateway to Global Innovation | The China International Import Expo (CIIE) is more than just an exhibition. It’s a vibrant marketplace where ideas meet opportunity. This year, Fosun International, a major player in the global healthcare landscape, showcased its innovation... |
| 07.11.2024 | Fosun Attends CIIE for the Seventh Time - Guo Guangchang: Confident that China's High-Level Openness is a Historical Opportunity | HONG KONG, Nov. 7, 2024 /PRNewswire/ -- On November 5, the 7th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center in Shanghai. As a seven-time attendee of the CIIE, Fosun showcased the latest achi... |
| 29.08.2024 | Fosun International: Navigating Growth Amidst Challenges | Fosun International Limited has emerged as a beacon of resilience in a turbulent economic landscape. The company recently reported its interim results for the first half of 2024, showcasing a robust performance that defies the odds. With to... |
| 28.08.2024 | Fosun Int'l: Total Revenue for 1H2024 Reaches RMB97.84 Bn, Industrial Operation Profit Amounts to RMB 3.47 Bn | Powered by Core Strengths, Focus on Core Businesses & Reinforce Organic Growth Momentum
2024 Interim Results Highlights:
Total revenue maintained growth, reaching RMB97.84 billion;
Industrial operation profit maintained growth, reaching... |
| 25.06.2024 | Insightec: Revolutionizing Healthcare with Focused Ultrasound Technology | Insightec, a healthcare company at the forefront of using focused ultrasound to revolutionize patient care, recently secured a whopping $150 million in equity financing. This funding round, led by Fidelity Management & Research Company,... |
| 24.06.2024 | Insightec: Focused Ultrasound Company Raises $150 Million | Insightec, a healthcare company dedicated to using focused ultrasound to transform patient care, announced it has raised an oversubscribed $150 million in equity financing. This round was led by Fidelity Management & Research Company an... |
| 19.06.2024 | Insightec Raises $150M in Equity Financing | Insightec, a Haifa, Israel- and Miami, FL-based healthcare company dedicated to using focused ultrasound to improve patient care, raised $150M in equity funding.
The round was led by Fidelity Management & Research Company and co-led by ... |
| 14.02.2024 | IMRIS and Insightec Enter Into a Collaboration to Enable Technology Integration | IMRIS & Insightec have entered into a collaboration agreement that will enable Insightec systems to seamlessly operate within IMRIS InVision™ Surgical Theatres.
IMRIS is excited to collaborate with Insightec to bring focused ultrasound ... |
| 12.05.2023 | An ultrasound device may unlock brain cancer treatment, early study shows | Brain cancer patients are left with few options when tumor cells spread, as most potent chemotherapies are unable to cross the blood-brain barrier. But a study published last week in the Lancet offers some hope: an ultrasound device implant... |
| 11.05.2023 | 10+ things to know in #MiamiTech: News from Betr, Blink Charging, Trav, Brightline, AWS, CIC, Watson Institute, FAU, Insightec, Taxfyle, Bevel & more | Facebook
Tweet
Pin
LinkedIn
Email
1 Betr launches in Massachusetts, makes key acquisition
This just in: Betr, the Miami-based sports betting startup founded by Joey Levy and Jake Paul, announced today that it has launched its real-money gam... |
| 02.09.2022 | Insightec receives up to $200M in financing to drive growth of incisionless neurosurgery | Facebook
Tweet
Pin
LinkedIn
Email
In another important milestone for Insightec and the future of incisionless neurosurgery, the medical technology company dedicated to using acoustic energy to transform patient care signed a credit facility... |
| 01.09.2022 | Insightec Receives up to $200M Financing | Insightec, a Haifa, Israel and Miami, FL-based healthcare company dedicated to using acoustic energy to transform patient care, signed a credit facility for up to $200 million with affiliates of existing shareholders Perceptive Advisors and... |
| 19.07.2022 | 6+ things to know in #MiamiTech: Realfinity & BCP Global fundings, new Miami Tech Charter now accepting students; Bitcoin 2023 returning in May – and much more | Facebook
Tweet
Pin
LinkedIn
Email
1 Fintech startup Realfinity raises $2M
Realfinity, a Miami-based fintech for the real estate world, said it raised $2 million in pre-seed funding. The startup said it intends to use the funds to continue t... |
| 01.12.2021 | Insightec Announces FDA Clearance For Exablate Prostate To Treat Prostate Tissue | Exablate Prostate system uses Focused Ultrasound guided by MRI
HAIFA, Israel and MIAMI, Fla., Dec. 1, 2021 /PRNewswire/ -- Insightec, a global healthcare company creating the next generation of patient care by realizing the therapeutic powe... |
| 03.11.2021 | Insightec Announces FDA Approval of Exablate Neuro for the Treatment of Parkinson's Disease | MIAMI, Nov. 3, 2021 /PRNewswire/ -- Insightec®, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy, announced today that the U.S. Food and Drug Administration (FDA)... |
| 20.09.2021 | India Ministry of Health and Family Welfare Approves Exablate Neuro Focused Ultrasound Platform | Insightec, a global healthcare company focused on transforming patient care, announced its incisionless neurosurgery platform, the Exablate® 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO), part... |
| 20.09.2021 | India Ministry of Health and Family Welfare Approves Exablate Neuro Focused Ultrasound Platform | HAIFA, Israel and MIAMI, Fla., Sept. 20, 2021 /PRNewswire/ -- Insightec®, a global healthcare company focused on transforming patient care, announced its incisionless neurosurgery platform, the Exablate® 4000, has received market approval b... |
| 09.08.2021 | Insightec Announces Seoul National University Hospital Is Installing Exablate Neuro Platform | Expanding patient access to incision-free Focused Ultrasound treatment
HAIFA, Israel and MIAMI, Aug. 9, 2021 /PRNewswire/ -- Insightec®, a global healthcare company focused on creating the next generation of patient care, announced Seoul Na... |
| 22.07.2021 | The $100M+ Dollar Club of Israeli Startups | Located at the eastern end of the Mediterranean Sea, Israel is a relatively small country, measuring 470 km north-to-south and 135 km east-to-west at its widest point. Despite its size, the country has a diverse topography- the hill regions... |
| 05.07.2021 | Insightec Announces Registration Approval Of Exablate Neuro By Singapore Health Sciences Authority | Positive momentum continues to bring Focused Ultrasound to global patients living with Essential Tremor and Tremor-dominant Parkinson's Disease
HAIFA, Israel and MIAMI, July 5, 2021 /PRNewswire/ -- Insightec®, a global healthcare company fo... |
| 27.04.2021 | Insightec Announces Positive Coverage Decision By Aetna For MR-guided Focused Ultrasound To Treat Essential Tremor | MIAMI, April 27, 2021 /PRNewswire/ -- Insightec®, a global healthcare company focused on creating the next generation of patient care, announced today that Aetna is the first national payor to cover MR-guided Focused Ultrasound for treating... |
| 27.04.2021 | Insightec Announces Positive Coverage Decision By Aetna For MR-guided Focused Ultrasound To Treat Essential Tremor
USA - English USA - English | |
| 24.11.2020 | INSIGHTEC Announces MR-guided Focused Ultrasound to Treat Essential Tremor Received Funding by National Health Service (NHS) England
USA - English
USA - English
USA - English
USA - English
España... | |
| 01.09.2020 | INSIGHTEC MR-Guided Focused Ultrasound Receives Reimbursement from Japanese Ministry of Health, Labour and Welfare for the Treatment of Parkinson's Disease
USA - English
USA - English
USA - English... | |
| 08.03.2020 | INSIGHTEC raises $150 million for medical technology focused on Parkinson’s, other diseases | Facebook
Tweet
Pin
LinkedIn
Email
INSIGHTEC, a commercial-stage medical technology company led by Maurice R. Ferré, announced on Friday that it has raised a Series F investment round of up to $150 million at a post-money valuation of $1.3 b... |
| 06.03.2020 | Insightec raises $150M for incisionless surgery | KDT is a repeat investor in the startup, having led a $150 million funding round in Insightec in 2017.
“Our partnership with KDT and other investors is helping to fuel our momentum as a rapidly growing number of medical institutions adopt o... |
| 13.02.2020 | Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date | OurCrowd is arguably the leading investment crowdfunding platform in the world. Based in Israel but listing offerings from companies around the world, OurCrowd has seen approximately $1.4 billion in committed funding since inception. Of the... |
| 11.07.2019 | Insightec wants to usher in a new era of incisionless surgery | Imagine – as an alternative – an outpatient procedure that harnesses the power of sound and gives tremor patients back their free movement in a few hours without a single incision. Tirat Carmel, Israel-based company Insightec is making that... |
| 07.03.2019 | OurCrowd Offers New $50 Million Medtech Fund for Investors | OurCrowd, the largest investment crowdfunding platform in the world, has announced the launch of the OurCrowd Medtech Fund joining their existing portfolio of 18 funds. The $50 million fund will focus exclusively on investing in disruptive ... |
| 07.03.2019 | Global Investment Platform OurCrowd Tops $1 Billion Raised, Reports 29 Exits | OurCrowd, the largest investment crowdfunding platform in the world, has topped $1 billion in funding raised. The online investment platform has provided growth capital to 170 individual firms and 18 different funds in the six years since t... |
| 07.09.2018 | Koch Disruptive Technologies’ Jason Illian to discuss investing in AI at VentureBeat’s Blueprint event | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Jason Illian, managing director of Koch Disruptiv... |
| 07.09.2018 | Koch Disruptive Technologies’ Jason Illian to discuss investing in AI at VentureBeat’s Blueprint event | Jason Illian, managing director of Koch Disruptive Technologies, is one of the speakers who will be appearing at VentureBeat’s upcoming Blueprint conference in York, Pennsylvania on March 26-28. At the event, speakers including Illian will ... |
| 07.03.2018 | What Koch Disruptive Technologies is looking for in its investments | Jason Illian is managing director of Koch Disruptive Technologies (KDT), a newly launched subsidiary of 70-year-old conglomerate Koch Industries. And Illian is aware that the general public doesn’t typically associate the name “Koch” with s... |
| 07.03.2018 | What Koch Disruptive Technologies is looking for in its investments | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Jason Illian is managing director of Koch Disrupt... |
| 02.02.2018 | Term Sheet — Friday, February 2 | IPO DELAYS
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
In an executive shakeup, Airbnb said its CFO, Laurence “L.T.” Tosi will be leaving the company and CEO Brian Chesky’s longtime deput... |
| 31.01.2018 | Insightech Closes $150M Series E Financing | Insightec, a Haifa, Israel, and Miami, Fla.-based commercial-stage medical technology company, closed a $150m Series E equity funding.
Koch Disruptive Technologies (KDT), a subsidiary of Koch Industries, focused on finding and funding innov... |
| 31.01.2018 | Insightec Raises $150M Series E | INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MRI-guided focused ultrasound (MRgFUS) announced today the closing of a $150 million Series E private equity investment round. Koch Disrupti... |
| 14.12.2017 | Insightec Raises $150M in Series E Funding | Insightec, a Haifa, Israel, and Miami, Florida-based commercial-stage medical device company innovating surgery with MRI-guided focused ultrasound, raised $150m in a Series E funding round.
The pre-IPO round was led by Koch Disruptive Techn... |
| 07.01.2016 | Insightec Secures $22M in Series D Funding | Insightec, a Dallas, Texas- and Haifa, Israel-based provider of a non-invasive therapy platform, secured $22M in Series D round of funding.
Founded in 1999, Insightec has developed Magnetic Resonance guided Focused Ultrasound (MRgFUS) techn... |
| 19.12.2014 | InSightec names Ferré for board, raises $59m for ExAblate fibroid device | Medtech funding for the week of December 15, 2014 | InSightec raises $59m, taps ex-Mako CEO Ferré for board December 15, 2014 by Brad Perriello
InSightec said today that it reeled in a $59 million Series D round from institutional investors in the U.S. and Asia and named Dr. Maurice Ferré as... |
| 15.12.2014 | InSightec Closes $59M Series D Financing | InSightec, a Dallas TX-based developer of a non-invasive therapy platform, closed a $59M Series D financing.
The round was led by major institutional investors in the United States and Asia. The company announced the option for existing sha... |
| 16.09.2014 | Funding: InSightec raises $12.5M from Chinese backers | Israeli device maker InSightec added $12.5 million to its coffers thanks to the support of Chinese backers, the firm’s parent company announced.
Elbit Imaging announced that its InSightec subsidiary sold more than 6.4 million Series D prefe... |
| 03.07.2014 | InSightec Raising $50M in Series D Funding | InSightec, a Tirat Carmel, Israel-based developer of MR-guided focused ultrasound (MRgFUS) therapy for the non-invasive treatment of tumors, is raising $50m in its current D funding round.
The investment will be used to accelerate market de... |
| 11.12.2012 | Funding: InSightec closes $30.9 million Series C round | InSightec picked off $30.9 million in a Series C financing round, led by a $27.6 million investment from GE Healthcare and $3.3 million by other investors, the company said.
In addition, the Israeli-based ultrasound maker also named VP &... |
| 10.12.2012 | InSightec Completes $30.9M Series C Financing | InSightec Ltd., an Israel-based global leader in MR guided Focused Ultrasound Surgery (MRgFUS), has completed a $30.9m Series C financing.
The round includes an investment of $27.6m by GE Healthcare and $3.3m by other investors.
The company... |
| 20.08.2012 | FDA approves brain ultrasound study with InSightec’s ExAblate Neuro | The FDA approved U.S. studies of Israel-based InSightec’s ExAblate Neuro in treatment of medication resistant Parkinson’s disease.
InSightec will enroll 30 patients who suffer from tremors associated with the disease, randomizing them for t... |
| 23.06.2010 | ExAblate® Receives European CE Mark for Treatment of Adenomyosis | Non-invasive procedure now available where options were limited; InSightec innovation continues to expand treatment choice in Women’s Health
TIRAT CARMEL, Israel (June 23, 2010) -- InSightec Ltd. announced today that its ExAblate® system ha... |
| 29.11.2007 | Life sciences briefing: Thursday, Nov. 29, 2007 | Featured companies: Adenosine Therapeutics, Allylix, Caprotec BioAnalytics, Equipois, F-Star, Insightec, MedNets.com, Renal Solutions, Transport Pharmaceuticals, VeriCare Management
UPDATED: Expanded items on Transport Pharmaceuticals, InSi... |
| - | Insightec wants to usher in a new era of incisionless surgery | Even the most basic movements like tying a pair of shoe laces, drinking a cup of coffee or snapping a selfie can be a daunting task for someone suffering from essential tremor.
In the United States, the condition affects millions of people.... |
| - | InSightec | “Focused Ultrasound is a minimally invasive, precision treatment of essential tremor with a mouse click. Check treatment eligibility and reclaim your life!” |
